Clinical Trials Logo

Clinical Trial Summary

Randomized controlled trial of the effect of a single-dose intravenous Vancomycin after catheter replacement for suspected central line-associated bloodstream infection on resolution of infection in critically ill patients.

Clinical Trial Description

Patients on the local intensive care unit with suspicion of central line-associated bloodstream infection will be randomized to standard of care consisting of catheter replacement and blood and catheter tip cultures and to standard of care plus a single-dose vancomycin. The effect of the intervention on resolution of humoral inflammation and negativity of blood cultures will be assessed after 48 and 96 hours. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT04856878
Study type Interventional
Source University of Zurich
Status Not yet recruiting
Phase Phase 4
Start date June 1, 2021
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT03282292 - Central Venous Catheter Insertion Site and Colonization in Pediatric Cardiac Surgery N/A
Completed NCT03898115 - Implementation Program to Improve CHG Bathing Compliance N/A
Completed NCT03253887 - Ethanol-lock Therapy for the Prevention of Non-tunneled Catheter-related Infection in Pediatric Patients Phase 3
Recruiting NCT01893060 - Umbilical Cord Care for the Prevention of Colonization N/A
Completed NCT00975923 - Safe Critical Care: Testing Improvement Strategies N/A
Enrolling by invitation NCT04559334 - Compassionate-Use of 4% T-EDTA Lock Solution for Central Venous Lines of Pediatric PN Patients N/A
Completed NCT03692559 - The Effects of Different Ways of Dressing Central Line Associated Bloodstream Infections N/A
Completed NCT02969343 - Patient Safety Learning Laboratory: Making Acute Care More Patient-Centered N/A
Completed NCT03486093 - Port Protectors for Prevention of CLABSIs in Respiratory Semi-intensive Care Unit N/A